Related Experiment Video
Updated: Aug 2, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation
Daniel A Bonsor1, Dhirendra K Simanshu1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Maryland, USA.
Abstract:
RAF activation is a key step for signalling through the mitogen-activated protein kinase (MAPK) pathway. The SHOC2 protein, along with MRAS and PP1C, forms a high affinity, heterotrimeric holoenzyme that activates RAF kinases by dephosphorylating a specific phosphoserine. Recently, our research, along with that of three other teams, has uncovered valuable structural and functional insights into the SHOC2-MRAS-PP1C (SMP) holoenzyme complex. In this structural snapshot, we review SMP complex assembly, the dependency on the bound-nucleotide state of MRAS, the substitution of MRAS by the canonical RAS proteins and the roles of SHOC2 and MRAS on PP1C activity and specificity. Furthermore, we discuss the effect of several RASopathy mutations identified within the SMP complex and explore potential therapeutic approaches for targeting the SMP complex in RAS/RAF-driven cancers and RASopathies.
Insights
The SHOC2-MRAS-PP1C complex activates RAF kinases, crucial for MAPK signaling. Understanding its structure and function offers new therapeutic targets for RASopathies and cancers.
Area of Science:
- Molecular Biology
- Cell Signaling
- Structural Biology
Background:
- RAF activation is central to the mitogen-activated protein kinase (MAPK) pathway.
- The SHOC2 protein, alongside MRAS and protein phosphatase 1 catalytic subunit (PP1C), forms a holoenzyme that activates RAF kinases.
- Recent studies have provided significant structural and functional insights into this SHOC2-MRAS-PP1C (SMP) holoenzyme complex.
Approach:
- Reviewing recent structural and functional data on the SMP complex.
- Analyzing SMP complex assembly and the role of MRAS nucleotide-bound states.
- Investigating the substitution of MRAS by canonical RAS proteins.
- Examining the contributions of SHOC2 and MRAS to PP1C activity and specificity.
Key Points:
- The SMP complex's assembly is dependent on the nucleotide-bound state of MRAS.
- SHOC2 and MRAS modulate the activity and specificity of PP1C.
- RASopathy-associated mutations within the SMP complex are discussed.
- Potential therapeutic strategies targeting the SMP complex for RAS/RAF-driven diseases are explored.
Conclusions:
- The SMP complex is a critical regulator of RAF activation within the MAPK pathway.
- Structural and functional insights into the SMP complex pave the way for targeted therapies.
- Understanding the SMP complex's role in RASopathies and cancers is essential for developing novel treatments.
More Related Videos
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
MAPK Signaling Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
cAMP-dependent Protein Kinase Pathways
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway